Sutphin Drugs Inc.   Report issue

For profit Phase 1
Founded: Jamaica NY United States (1982)

Organization Overview

First Clinical Trial
2019
NCT03975374
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Sutphin Drugs

Active Ingredients

Drugs in Phase 1 Trials (4)

dexamethasone (1 trial)

doxorubicin (Doxil) (1 trial)

fluconazole (diflucan) (1 trial)

tobramycin (nebcin) (1 trial)

Drugs in Other Trials (1)

nitisinone (orfadin) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Candidiasis (Phase 1)

Conjunctivitis (Phase 1)

Leukemia (Phase 1)

Lymphoma (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 4
  • # of Trial APIs: 5